Pricing Log in Create free account

AC Immune (ACIU) vs Korro Bio, Inc. (KRRO)

AC Immune and Korro Bio, Inc. are both Biotechnology companies. AC Immune is the larger, with a market value of $227.0M against $202.5M — 1.1× the size. AC Immune grew revenue faster over the last twelve months: −78.6% against −81.9%. Korro Bio, Inc. has the higher net margin (0.00% vs −962.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Korro Bio, Inc. leads on 8 and AC Immune on 5.

Valuation

Metric ACIU KRRO Biotechnology median
P/E n/m n/m 10.60
P/S 21.29 40.65 9.40
P/B 4.52 2.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 9.06 25.53 9.02
Earnings yield (32.74%) (67.80%) (32.88%)
Free cash flow yield (55.75%) (26.27%) (23.13%)

Profitability

Metric ACIU KRRO Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (986.55%) 0.00% 0.00%
Net margin (962.17%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (122.01%) (97.69%) (51.96%)
Return on assets (33.75%) (62.03%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACIU KRRO Biotechnology median
Revenue growth (TTM) (78.60%) (81.87%) 6.76%
EPS growth (last fiscal year) (44.83%) (33.19%) 29.88%
Revenue growth, 5-year CAGR (47.84%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACIU KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.85 9.55 4.97
Net debt to EBITDA 1.37 0.64 1.01

Dividend

Metric ACIU KRRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACIU KRRO Biotechnology median
Market cap 226.96m 202.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack